New data analysis on Tirbanibulin shows consistent treatment response for actinic keratosis (AK): data from phase IV and real-world evidence studies show consistently high levels of response as well ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Dr ...
A panelist discusses how new data from the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates tildrakizumab’s efficacy in treating nail psoriasis, with the 100-mg dose showing ...
One week after the AAD meeting, Christopher J. Sayed, MD, reflects on the lessons learned about hidradenitis suppurativa (HS) and the evolving approach to patient care. A key takeaway is the shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback